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Abstract Intracellular localization of FBPase in the cardiac
muscle of the pig was studied by immunohistochemistry. In con-
trast to data from skeletal muscle [Gizak, A., Rakus, D. and
Dzugaj, A. (2003) Histol. Histopathol. 18, 135^142], in cardio-
myocytes FBPase was present not only in the cytoplasm, but
surprisingly, also in the nucleus. Results of the microscopic in-
vestigation were con¢rmed by immunoblotting, measurement of
FBPase activity in isolated cardiomyocyte nuclei and by deter-
mination of the nuclear FBPase I0:5 toward adenosine mono-
phosphate (AMP), which was the same as for the puri¢ed en-
zyme.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate
1-phosphohydrolase, EC 3.1.3.11, FBPase) catalyzes the hy-
drolysis of fructose-1,6-bisphosphate to fructose-6-phosphate
and inorganic phosphate, in the presence of divalent metal
ions like magnesium, manganese, cobalt or zinc [1,2]. Verte-
brate FBPases are inhibited competitively by fructose-2,6-bis-
phosphate, and allosterically by adenosine monophosphate
(AMP) [3,4].
Liver and muscle isozymes have been found in vertebrate
tissues [2,5,6]. The liver FBPase is recognized as a regulatory
enzyme of gluconeogenesis. The muscle isozyme participates
in the glycogen synthesis from lactate and in the regulation of
glycolysis [7^9]. The basic di¡erence between the liver and
muscle isozymes concerns their sensitivity to AMP inhibition.
In the case of the muscle enzyme, the I0:5 value for AMP is
about 0.1 WM, and it is 10^100 times lower than the same
value determined for the liver isozyme [2,10^12].
Tissue distribution of FBPase isozymes has been investi-
gated. The liver isozyme has been found primarily in gluco-
neogenic tissue like liver, kidney, and lung. In skeletal muscle
tissue only the muscle isozyme is expressed, but in other tis-
sues simultaneous expression of the two isozymes has been
observed [6].
Not many papers are available on cellular and subcellular
FBPase isozymes localization. Schmoll et al. [13] have found
FBPase to be an astrocyte-speci¢c enzyme. Gizak et al. [14]
have located FBPase in pneumocyte II. Saez et al. [15] have
reported that in hepatic and renal cells FBPase is located in
the perinuclear area. Recently Gizak et al. have located
FBPase on both sides of the Z-line of skeletal muscle [16].
The primary aim of the present paper is to locate FBPase in
subcellular structures of cardiomyocytes. Evidence for local-
ization of FBPase in the nuclei of cardiomyocytes is pre-
sented, and physiological meaning of this ¢nding is discussed.
2. Materials and methods
Antibody diluent and 3,3P-diaminobenzidine (DAB) chromogen
were purchased from Dako (USA), Paraformaldehyde, glutaralde-
hyde, Coomassie brilliant blue R-250 were from Fluka (Switzerland);
polyester wax was from EMS (USA). Anti-rabbit IgG gold conju-
gated (10 nm) was from ICN (USA). Biotin conjugated mouse mono-
clonal anti-rabbit immunoglobulins, extravidin-horseradish peroxi-
dase, normal sera, nitrocellulose membranes and other reagents
were from Sigma (USA).
All the reagents were of the highest purity commercially available.
2.1. Antibody production and Western blot
Antiserum against the muscle FBPase was raised in a rabbit by
intracutaneous injection of the electrophoretically pure enzyme (iso-
lated from fresh rabbit skeletal muscle according to [17]) and Freund’s
complete adjuvant. Immunoserum was partially puri¢ed using acetone
powder. Reactivity of the anti-FBPase serum was estimated using the
double di¡usion method [18]. Immunodi¡usion resulted in a strong
reaction between the antiserum and the pure enzyme. To check spec-
i¢city of the antibodies immunoblotting was performed as described
by Towbin et al. [19].
2.2. Immunohistochemistry
2.2.1. Light microscopy. Fresh porcine heart was provided by a
local slaughterhouse. Tissue was ¢xed in Bouin’s £uid and embedded
in polyester wax. Immunostaining of 5 Wm sections was carried out as
described previously [16] and involved incubation of the sections with
anti-muscle FBPase antibody, biotinylated secondary antibody, and
extravidin-biotinylated peroxidase complex.
In control reactions the primary antibody was omitted, or normal
rabbit serum was used as a ¢rst layer.
2.2.2. Electron microscopy. Small fragments of porcine heart
muscle tissue were ¢xed in 4% paraformaldehyde and 0.25% glutaral-
dehyde in phosphate bu¡er, and embedded in epon. Sections were
mounted on nickel grids. Before immunostaining, sections were incu-
bated with 2% normal goat serum, 1% bovine serum albumin (BSA)
and 50 mM glycine in Tris-bu¡ered saline (TBS)-Tween. Then they
were incubated with polyclonal antibodies against muscle FBPase (in
dilution 1:100^1:1000) overnight at 4‡C, washed with TBS and incu-
bated with goat anti-rabbit antibodies gold conjugated (1:200) for 1 h
at room temperature (RT). The grids were thoroughly washed with
TBS and distilled water to remove unbound antibodies. Before micro-
scopic examination the sections were stained with uranyl acetate.
In controls the primary antibody was omitted, or non-immune rab-
bit serum was used as a ¢rst layer.
2.3. Heart muscle fractionation
5 g of porcine ventricles were placed in nine volumes of bu¡er A
(10 mM HEPES, 1 mM dithiothreitol (DTT), 0.1 mM ethyleneglycol-
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bis-(L-aminoethylether)-N,N,NP,NP-tetraacetic acid (EGTA), 0.1 mM
ethylenediamine tetraacetic acid (EDTA), 1 mM phenylmethylsulfonyl
£uoride (PMSF), 2 mM MgCl2, 0.25 M sucrose; pH 7.4, at 4‡C) and
homogenized. The homogenate was ¢ltered through two and four
layers of cheesecloth and fractionated by di¡erential centrifugation
method [20].
Each pellet was dissolved in a small amount of bu¡er and centri-
fuged again for maximal removal of cytosol. Fractions were pre-in-
cubated with 0.5% Triton for 15 min at RT, and FBPase activity was
measured.
2.4. Isolation of cardiomyocyte nuclei
Cardiomyocyte nuclei were isolated using a non-enzymatic extrac-
tion technique as described by Boheler et al. [21]. All steps were
performed at 4‡C or on ice.
5 g of porcine ventricles were placed in nine volumes of bu¡er A
and homogenized for 15 s.
The homogenate was ¢ltered as described above and centrifuged at
1000Ug for 10 min. The pellet was resuspended in 15 volumes of
bu¡er, ¢ltered through Millipore ¢lter (pore size 41 Wm) and centri-
fuged as before. The pellet was resuspended in 10 ml of bu¡er with
0.5% Triton X-100 to further lyse the cells, centrifuged as before, and
¢nally resuspended in 2 volumes of bu¡er containing 10 mM HEPES,
1 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM PMSF, 2 mM
MgCl2, 2.2 M sucrose; pH 7.4, at 4‡C. Nuclei resuspended in the
above-mentioned bu¡er were layered on two ice-cold layers of sucrose
(2.7 M and 2.4 M sucrose) and centrifuged in TLS-55 Beckman rotor
at 36 000 rpm for 2 h. After centrifugation, cardiomyocyte nuclei
could be isolated at the interface of the 2.4/2.7 M sucrose.
Then the nuclei were suspended in appropriate volume of bu¡er
with 0.25 M sucrose to achieve 2.2 M ¢nal concentration of sucrose,
and layered again on sucrose gradient and centrifuged as described
above. These steps were performed to ensure high purity of cardio-
myocyte nuclei.
To determine the number of isolated nuclei, Thom-Zeiss cell was
used.
FBPase activity was assayed in 50 mM Bis Tris Propane (BTP),
2 mM MgCl2, 150 mM KCl, 1 mM EDTA, 0.2 mM nicotinamide
adenine dinucleotide phosphate (NADP), 5 units/ml glucose-6-phos-
phate dehydrogenase, 2 units/ml glucose-6-phosphate isomerase, 50
WM fructose-1,6-bisphosphate, pH 7.5; the assay was carried out at
37‡C. The substrate was used to start the reaction.
For measuring the inhibition of heart muscle cytosolic and nuclear
FBPase by AMP, concentration of AMP was determined using 15 400
M31 cm31 as the molar absorption coe⁄cient at 259 nm. I0:5 was
calculated with the use of GraFit program [22].
3. Results
3.1. Immunolocalization of FBPase in the pig heart
Examination of pig heart muscle tissue with light microsco-
py revealed strong positive reaction in the nuclei of the car-
diomyocytes and, much weaker, in the cytoplasm (Fig. 1A).
No labeling occurred in the absence of the primary antibody,
or when the normal serum was used instead of the primary
antibody (Fig. 1B).
To check speci¢city of the interaction between the antise-
rum and its antigen, Western blot was performed. Results
showed one band of 37 kDa in the homogenate of the pig
heart, corresponding to puri¢ed muscle FBPase, indicating
that antibodies against rabbit muscle FBPase react with
FBPase, but do not react with other proteins from pig heart
crude extract (Fig. 2).
Analysis of ultrathin sections of heart muscle tissue under
the electron microscope and gold conjugated secondary anti-
body has corroborated the results obtained from light micros-
copy. Additionally, in nuclei, positive reaction was restricted
to the heterochromatin area (Fig. 3A). In cytoplasm, weak
staining was observed on the Z- and M-lines (Fig. 3B). No
labeling occurred in the absence of the primary antibody, or
when the normal serum was used as a ¢rst layer (Fig. 3C, D).
The same results were obtained from rat heart tissue analysis
(data not shown).
3.2. Pig heart fractionation and isolation of cardiomyocyte
nuclei
Activity of FBPase from seven porcine hearts was investi-
gated in the course of this study. Fractions obtained through
di¡erential centrifugation enabled a preliminary estimation of
subcellular distribution of FBPase.
FBPase activity was clearly detectable in the initial homog-
enate, but not in particulate subcellular fractions (Table 1).
Pre-incubation with Triton X-100, however, resulted in a 1.8-
fold increase of FBPase activity in the homogenate and in the
appearance of activity in the nuclear fraction, which consti-
tuted 2.6% of the homogenate activity. Very low level of
FBPase activity was also found in the microsomal fraction.
Control reaction indicated that Triton had no e¡ect on
FBPase activity determination.
The enzyme activity found in the ¢nal high-speed superna-
tant (data not shown) was similar to that of the initial step of
A B
Fig. 1. A: FBPase in pig heart muscle. Arrows point to cardiomyocyte nuclei. B: Control reaction. Bar= 20 Wm.
Table 1
Subcellular distribution of FBPase from pig heart
Fraction FBPase activity
(U/g tissue)
% Activity
A Ba
Homogenate 0.29 0.53 100
Nuclear fraction 0 0.014 2.6
Mitochondrial fraction 0 0 0
Microsomal fraction 0 0.001 0.18
Cardiomyocyte nuclei 0 0.006 1.14
aFractions pre-incubated with Triton X-100.
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fractionation, indicating that no activity was lost during the
experiment.
It is well known that non-cardiomyocyte nuclei constitute
about 70% of all cardiac nuclei [23]. A non-enzymatic extrac-
tion technique [21] was used to isolate a pure fraction of
cardiomyocyte nuclei from the total pool. Importantly, this
technique ensured that no cytosol remained in the fraction.
No residual contamination by myo¢laments or membranes
was observed.
The isolated fraction of myocyte nuclei was then analyzed
for FBPase by both immunoblotting and activity measure-
ment. No detectable activity was found in the fraction not
pre-treated with Triton. After incubation with Triton the ac-
tivity of FBPase detected in myocyte nuclei constituted 1.14%
of the activity in the homogenate (Table 1).
Western blot analysis of the nuclei resulted in a thin single
band that migrated identically to puri¢ed muscle FBPase
(Fig. 4).
To determine the size of cardiomyocytes from para⁄n-em-
bedded material, ocular micrometry was used; in addition, a
morphometric study of cardiomyocyte nuclei was performed,
and nuclear volume was calculated. Assuming that mean nu-
clear volume was 307 Wm3, concentration of FBPase in the
nucleus was about 0.61 WM comparing with 0.127 WM in the
whole cardiomyocyte.
3.3. Inhibition by AMP
Al-Robaiy and Eschrich [16] have observed that in rat heart
muscle there is not only high expression of muscle FBPase
isozyme, but also low expression of liver FBPase mRNA.
This encouraged the speculation that in pig cardiomyocytes
the muscle FBPase isozyme is expressed in cytosol, while the
liver isozyme in the nuclei.
Because the most characteristic kinetic property of the
muscle isozyme is its high sensitivity towards AMP
(I0:5 = 0.1 WM AMP, while for the liver isozyme it is 10^100
times higher), I0:5 was determined for FBPase from pig car-
diomyocyte cytosol and nuclei.
Results of the experiment (Fig. 5) indicate that FBPase
from both fractions was inhibited in the same manner, with
I0:5 values characteristic for the muscle isozyme (I0:5 = 0.067
WM for cytosolic and 0.058 WM for nuclear fraction).
4. Discussion
Presence of FBPase in the nuclei of cardiomyocytes was
detected by light and electron microscopy and con¢rmed by
Western blot. Determining the I0:5 for FBPase for AMP from
the heart homogenate and from the puri¢ed nuclear fraction
(which was the same as for the puri¢ed enzyme, in the range
Fig. 2. Western blot of 25 Wl of pig heart homogenate (left lane)
and puri¢ed muscle FBPase (right lane).
A
C
B
D
Fig. 3. Localization of FBPase in cardiomyocyte nucleus (A) and cytoplasm (B). C, D: Control reactions. Bar= 0.5 Wm.
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of experimental error) proved FBPase’s presence. Although
FBPase activity in nuclei consists of ca. 1% of the total en-
zyme activity, its concentration therein is four to ¢ve times
higher than in the cytosol. Thus, non-covalent binding of
FBPase with nuclear structures may be expected. Detection
of FBPase activity only in nuclei pre-treated with Triton sup-
ports the above hypothesis.
The presence of FBPase in the nuclei of cardiomyocytes
raises a question concerning its physiological role. Several
enzymes of carbohydrate metabolism have so far been found
in cell nuclei : glucokinase [24], aldolase [25], glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), lactate dehydrogenase
(LDH), phosphoglycerate kinase (PGK) (for review see:
[26]), and glycogen synthase [27], and their physiological roles
have been discussed. Unlike glycogen synthase, whose func-
tion is supposedly the same in the cytosol and the nucleus, the
other enzymes’ physiological roles seem to vary from cytosol
to the nucleus. It has been hypothesized that PGK may par-
ticipate in DNA synthesis and cell cycle progression [28].
GAPDH recognizes the sequence and structural features of
the RNA and is involved in transcription [29] ; LDH is a
recognized stabilizing nuclear factor, and it participates in
DNA reparation [28].
One of the signals directing protein to the nucleus is phos-
phorylation. There is no evidence on in vivo phosphorylation
of liver FBPase. On the other hand, Rakus et al. [12] have
found that rabbit muscle isozyme is phosphorylated. Phos-
phorylated FBPase has higher a⁄nity to aldolase, which in-
creases a muscle cell’s gluconeogenic capacity [12]. In the liver,
stimulation of gluconeogenesis goes via phosphorylation of
fructose-2,6-bisphosphatase/6-phosphate-2-fructokinase (FBP-
ase2/PFK2). The muscle isozyme of FBPase2/PFK2 cannot be
phosphorylated, therefore, di¡erent regulation of gluconeo-
genesis may be expected. The activation of muscle gluconeo-
genesis may proceed via phosphorylation of FBPase. That
might be the signal inducing the movement of the enzyme
to the nucleus where it could induce the expression of its
own gene, thus increasing the cell’s gluconeogenic capacity,
although a possibility that FBPase in£uences the expression
of other genes cannot be ruled out.
A great number of proteins entering the nucleus possess a
characteristic nuclear localization sequence (NLS) in their pri-
mary structure. One of such sequences is the KKKGK motif
[30]. It is present in all known muscle (but not liver ^ except
human liver) FBPase sequences (human, rabbit, rat and
mouse), and it could potentially act as an NLS. Although
the primary structure of pig muscle FBPase has not yet
been determined, all muscle FBPases are characterized by a
very high degree of homology (99%) and identity (95%).
Therefore the same NLS in pig muscle FBPase might be ex-
pected.
Our paper is the ¢rst unequivocal report on localization of
muscle FBPase in the nuclei of cardiomyocytes.
In skeletal muscle, FBPase has been located on both sides
of the Z-line [16]. Heart muscle, like skeletal muscle, is con-
sidered a striated muscle. Nonetheless, di¡erences in metabol-
ic pathways and their regulation between these two types of
muscle are well documented; therefore, di¡erent subcellular
localization and di¡erent physiological role of FBPase in skel-
etal and heart muscle may be expected.
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